- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8725
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,725 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
300286 | CN¥19.63 | -0.3% | -30.5% | CN¥4.2b | CN¥33.30 | PE22.3x | E32.0% | 1.0% | Capital Goods | ||
ICOP | €7.24 | 2.3% | n/a | €200.1m | €9.30 | PE39.6x | E49.2% | n/a | Capital Goods | ||
YGG | ฿0.57 | -12.3% | -92.2% | ฿343.1m | ฿10.75 | PS1.2x | E85.5% | 47.0% | Media | ||
PHM | €74.55 | -3.5% | 103.5% | €1.3b | €84.60 | PE2102.1x | E56.4% | 0.9% | Pharmaceuticals & Biotech | ||
RHM | €575.80 | 5.5% | 106.3% | €25.0b | €639.40 | PE36.5x | E28.6% | 1.0% | Capital Goods | ||
NVDA | US$141.98 | -3.8% | 188.0% | US$3.5t | US$160.38 | PE65.7x | E23.3% | 0.03% | Semiconductors | ||
BTR | AU$0.022 | -10.2% | 46.7% | AU$156.9m | AU$0.05 | PS148.8x | E84.6% | n/a | Materials | ||
ANUP | ₹3,534.35 | -0.8% | 162.0% | ₹70.7b | ₹3,850.00 | PE59x | E21.5% | 0.2% | Capital Goods | ||
002827 | CN¥31.89 | -4.8% | 81.3% | CN¥8.8b | n/a | PE70.1x | E46.7% | 0.5% | Materials | ||
AFISH | NOK 65.50 | -12.7% | -18.1% | NOK 2.1b | NOK 81.00 | PE64x | E94.4% | n/a | Food, Beverage & Tobacco | ||
FND | AU$7.50 | 14.2% | 530.3% | AU$367.7m | AU$6.73 | PE91.1x | E64.8% | n/a | Diversified Financials | ||
156A | JP¥591.00 | -8.1% | n/a | JP¥5.8b | n/a | PE8.2x | E24.0% | 4.2% | Media | ||
AXSM | US$93.17 | 3.4% | 55.6% | US$4.5b | US$129.41 | PS13.3x | E72.5% | n/a | Pharmaceuticals & Biotech | ||
MBTN | CHF 0.44 | -62.6% | -99.8% | CHF 13.5m | CHF 6.03 | PS0.2x | E111.6% | n/a | Semiconductors | ||
CCOLA | ₺49.52 | 8.4% | 30.9% | ₺138.6b | ₺85.53 | PE10.8x | E42.0% | 1.4% | Food, Beverage & Tobacco | ||
TGTX | US$29.54 | 2.5% | 144.7% | US$4.2b | US$37.22 | PS16x | E56.5% | n/a | Pharmaceuticals & Biotech | ||
BBT | AU$0.26 | -1.9% | 26.8% | AU$147.1m | AU$0.35 | PS2.5x | E91.4% | n/a | Consumer Services | ||
RMDA | ج.م3.56 | -2.7% | 134.2% | ج.م5.4b | ج.م4.11 | PE23.6x | E30.2% | 1.9% | Pharmaceuticals & Biotech | ||
CONCORDBIO | ₹1,897.75 | 2.6% | 48.2% | ₹198.5b | ₹2,041.25 | PE60.5x | E26.9% | 0.5% | Pharmaceuticals & Biotech | ||
A179900 | ₩22,250.00 | 4.0% | -29.9% | ₩352.0b | ₩60,000.00 | PS17.6x | E134.6% | 0% | Tech | ||
ACE | SEK 2.63 | -3.0% | -9.3% | SEK 252.2m | SEK 8.25 | PB2.3x | E47.2% | n/a | Pharmaceuticals & Biotech | ||
7373 | JP¥1,595.00 | -0.9% | -13.6% | JP¥24.4b | JP¥4,700.00 | PE17.1x | E22.5% | 1.9% | Commercial Services | ||
MVW | NOK 9.55 | -2.6% | 41.7% | NOK 312.5m | NOK 12.20 | PS18.2x | E70.8% | n/a | Materials | ||
300848 | CN¥19.50 | -9.0% | 19.1% | CN¥8.1b | CN¥15.00 | PE117x | E80.2% | 0.4% | Materials |